检索

标题
作者
Herpes viruses and human papillomavirus in prostate cancer: first results
Mikhaleva L., Kamalov А., Karpov V., Okhobotov D., Akopyan E., Shakhpazyan N., Shaparov B., Nesterova O., Martirosyan L., Ekhoyan М., Osmanov О.
Robot-assisted prostatectomy for pT3. Oncological and functional outcomes
Medvedev R., Kolontarev K., Govorov А., Skrupskii К., Vasiliev А., Dyakov V., Kotelnikova А., Vitoslavsky А., Pushkar D.
Organ-sparing treatment of prostate stromal tumor of uncertain malignancy potential
Boshchenko V., Maspanov D., Lozovsky M., Kuchina E., Zavyalova M.
The actual concept of salvage therapy for local recurrence prostate cancer after radical prostatectomy
Pavlov A., Dzidzaria A., Tsibulskii A., Mirzakhanov R.
Efficiency and safety of the drug adenoprosin in patients with prostate diseases. A systematic review and meta-analysis
Morozov А., Timofeeva Е., Suvorov А., Allenov S., Spivak L.
Robot-assisted radical prostatectomy in patients after transurethral resection of the prostate
Skrupskiy K., Kolontarev K., Medvedev R., Pushkar D.
Evaluation of the effect of Alfuprost® MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia
Kuzmenko A., Kuzmenko V., Gyaurgiev T.
Giant prostate stones: case report
Katibov M., Bogdanov A., Magomedov Z., Mollaeva K.
HIFU therapy of localized prostate cancer using image-guided robotic hifu «Focal one»
Govorov A., Vasilyev A., Alaverdyan A., Kolontarev K., Pushkar D.
The results of the multicenter prospective comparative study of Fndrogel in men with endogenous testosterone deficiency and lower urinary tract symptoms, associated with benign prostate hyperplasia («Potok»)
Kogan M., Avadieva N., Gevorkyan L., Loginov Y., Metelkin A., Mitin A., Patrikeev A.
The comparative analysis of surgical procedures a in patients with benign prostatic hyperplasia and type 2 diabetes mellitus
Volkov S., Mikheev R., Grigoryan O., Andreeva E.
Ejaculatory disorders after surgical treatment of benign prostatic hyperplasia
Rustamov M., Galiullin O., Vinarov A.
On extended biopsy of the prostatic gland
Chepurov A., Vladimirov V., Zerinskaya S., Meshkov V., Ko baladze K., Iremashvili V., Chepurov A., Vladimirov V., Zerinskaya S., Meshkov V., Kobaladze K., Iremashvili V.
Antibacterial prophylaxis with fosfomycin at the time of the urethral catheter removal after radical prostatectomy (prospective randomized trial)
Veliev E., Sokolov E., Metelev A., Aliev E., Polyakova A., Ivkin E.
Experience in performing robot-assisted radical prostatectomy in patients after heart transplantation
Mosoyan M., Shelipanov D., Fedotov P., Fedorov D., Simonenko M.
Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy
Popov S., Guseinov R., Skryabin O., Orlov I., Martov A.
X-RAY-GUIDED ENDOVASCULAR SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Neimark A., Tachalov M., Neimark B., Torbik D., Arzamastsev D.
Pathomorphological features of prostate diseases
Kovylina M., Pushkar D.
The use of prostate extract preparations in patients after transurethral resection of prostate for its benign hyperplasia
Pavlov V., Kazikhinurov A., Kazikhinurov R., Sabirzyanov S., Saleeva Y., Kazikhinurova K.
The role of angiotensinconverting enzyme and angiotensin II receptors of the second type in the pathogenesis of proliferative diseases of the prostate
Chibichyan M., Chernogubova E., Avetyan A., Lapteva T., Pavlenko I., Kogan M.
Multicenter randomized study of bovhyalu-ronidase azoximer (Longidaza®) in men after transuretral resection of the prostate
Kotov S., Bolotov A., Belomyttsev S., Surenkov D., Vorobyova A.
Lower urinary tract symptoms after transurethral resection of the prostate
Ergakov D., Martov A., Turin D., Andronov A.
MODERN IDEAS ABOUT BULBOURETHRAL GLANDS
Kutia S., Radkovskij V., Astafurov D., Lugin I., Yarovaya O.
PREDICTORS FOR LOCOREGIONAL RECURRENCE AFTER RADICAL PROSTATECTOMY
Petrovskij N., Krupinov G., Amosov A., Chinenov D., Gerasimenko N., Glybochko P.
VITAPROST FORTE IN THE TREAMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: PATHOGENETIC BASICS AND CLINICAL RESULTS
Kuz’min I.
Use of multiparametric magnetic resonance imaging in t-staging of prostate cancer: a multicenter study
Abdullin I., Kossov F., Kamolov B., Kapustin V., Grigor’ev N., Gubskii I., Chernyaev V., Panov V., Buidenok Y., Matveev V.
CONTEMPORARY MARKERS AND HISTOLOGICAL FEATURES OF PROSTATE CANCER
Vasilyev A., Prilepskaya E., Kovylina M., Govorov A., Sadchenko A., Sidorenkov A., Pushkar D.
Cancer and genitourinary tuberculosis (literature review and clinical observations)
Kholtobin D., Kulchavenya E., Khomyakov B.
Review of clinical studies on combination therapy of 5a-reductase inhibitors and аі-blockers in patients with benign prostatic hyperplasia
Spivak L., Lokshin K., Vinarov A.
A role of MRI-Ultrasound fusion targeted biopsy of prostate in the diagnosis of prostate cancer
Shestopalova O., Jakovenko A., Rumyantsev A., Matveev A., Nevirovich E.
Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer
Govorov A., Vasilyev A., Pushkar D.
Benefit of primary saturational biopsy in detection of localized prostatic cancer after radical prostatectomy
Veliev E., Obeyd A., Bogdanov A., Veliev E., Obeid A., Bogdanov A.
INTRAVESICAL PROSTATIC PROTRUSION IN DIAGNOSING INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G., Efremov N., Bolotov A.
THE USE OF PROSTADOZ IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND COEXISTENT HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA
Antonov A., Gordeev V., Fedorchuk S., Laptev D.
Therapeutic efficacy and safety of monotherapy Alfuprost® MR 10 mg/day in clinical practice
Novikov A., Shpilenya E.
Clinical and morphological assessment of the results of a standard robot-assisted nerve-sparing radical prostatectomy and with the use of Retzius-sparing technique
Golubtsova E., Veliev E., Sokolov E., Paklina O., Knyshinsky G.
Clinical, morphological and microcirculatory criteria of local recurrence of the prostate cancer after HIFU therapy
Neymark A., Tachalov M., Neymark B., Levin V.
Efficacy of 5a-reductase inhibitors in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia
Nizov A.
IMPACT OF PD-L1 STATUS ON THE LONG-TERM OUTCOMES OF RADICAL TREATMENT OF PATIENTS WITH PROSTATE CANCER
Matveev V., Kirichek A., Safronova V., Khafizov K., Filippova M., Lyubchenko L.
The efficacy of fesoterodine in patients after transurethral resection of the prostate
Kuz’menko A., Kuz’menko V., Gyaurgiev T.
Russian experience with Vitaprost Forte suppositories in patients with lower urinary tract symptoms and benign prostatic hyperplasia: comparative analysis of studies
Korneev I.
ROLE OF ANGIOTENSIN II RECEPTOR TYPE 2 IN PREDICTING BIOCHEMICAL RECURRENCE IN THE TREATMENT OF PROSTATE CANCER
Chibichyan M., Kogan M., Chernogubova E., Pavlenko I., Matishov D.
THE HISTORY OF DISCOVERY OF BULBOURETHRAL GLANDS
Kutia S., Sataeva T., Nikolaeva N., Printseva N., Moroz G.
Use of flexible needles and ways to control their placement in robot-assisted prostate brachytherapy
Lopota A., Gryaznov N., Senchik K., Kharlamov V., Nikitin S., Kireeva G.
Comparative Analysis of Positive Surgical Margin Rates in Patients Undergoing Robot- Assisted or Retropubic Radical Prostatectomy for Prostate Cancer
Veliev E., Sokolov E., Loran O.
VALUE OF THE -2PROPSA INDEX AND THE PROSTATE HEALTH INDEX IN PATIENTS WITH PROSTATE CANCER: REVIEW OF LITERATURE AND DATA OF RUSSIAN PROSPECTIVE STUDY
Kolontarev K., Govorov A., Osipova T., Sidorenkov A., Pushkar D.
Daily intake of phosphodiesterase type 5 inhibitors - correction of erectile dysfunction and lower urinary tract symptoms in patients with bph
Volkov A., Petrichko M., Budnik N.
Urination disorders. Do we know all about them?
Gadzhieva Z., Kazilov Y., Alyaev Y., Aboyan I., Kazilov B.
Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia
Neymark A., Nozdrachyov N.
PROSTATE BIOPSY IN THE OUTPATIENT SETTING
Rokhlikov I., Samsonov A., Onishchenko O., Andreyev Y., Makanin M.
PROSTATIC CANCER IN MALES LIVING IN THE KHABAROVSK, KOMSOMOLSK-ON-AMUR AND KHABAROVSK REGION
Pisareva L., Rozner V., Boyarkina A., Odintsova I., Gurina L.
Experience in vitaprost treatment of patients with chronic abacterial prostatitis and prostatic adenoma after prostatic arteries embolism
Yakovets Y., Yakovets E., Neymark A., Karpenko A., Arzamastsev D., Yakovets Y., Yakovets E., Neimark A., Karpenko A., Arzamastsev D.
Pharmacourodynamic non-invasive studies in patients with prostatic adenoma
Danilov V., Vasil'chenko A., Danilova T., Besedin S., Borshchenko S., Danilov V., Danilov V., Vasilchenko A., Danilova T., Besedin S., Borschenko S., Danilov V.
Efficacy and safety of combined treatment of prostatic adenoma with 5-alpha reductase and alpha-adrenoblockers
Tkachuk V., Al-Shukri S., Tkachuk I., Mosoyan M.
Rare localization of prostate cancer single metastasis. Clinical case and literature review
Selivanov S., Barysheva E., Shikunova Y.
CURRENT METHODS OF EARLY DIAGNOSIS OF PROSTATE CANCER
Govorov A., Vasilyev A., Shiryaev A., Sukhikh S., Sidorenkov A., Pushkarev A., Tsiganov D., Pushkar’ D.
QUALITY OF LIFE IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AFTER TURP FOR BENIGN PROSTATIC HYPERPLASIA
Pushkar D., Bernikov A., Khodyreva L., Dudareva A., Al'-Shukri S., Amdii R., Aboyan I., Shiranov K., Medvedev V., Efremov M.
Our experience of holmium laser enucleation of the prostate
Kutluev M., Safiullin R.
The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A., Vinnik Y., Kuzmenko V., Gyaurgiev T.
Combination of a1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study
Borisov V.
Diagnostic utility of positronic emission tomography in recurrences of prostate cancer
Petrovskiy N., Glybochko P., Dolgushin M., Krupinov G., Shariya M., Meshcheryakova N.
Fusion biopsy of the prostate
Okishev A., Govorov A., Vasilyev A., Bormotin A., Pushkar D.
Prostate cancer prevention. the current trends
Karpov E.
Approaches to medical management of patients with high risk of progressing of benign prostatic hyperplasia depending on concomitant erectile dysfunction
Kamalov A., Takhirzade A.
Contemporary aspects of using sildenafil
Efremov E., Kasatonova E., Mel’nik Y., Simakov V.
EFFECT OF HYPERCAPNIC HYPOXIA ON CHRONIC ABACTERIAL PROSTATITIS
Neimark A., Maksimova S.
Prostadoz - opportunity for prostate cancer prevention?
Alyaev Y., Rapoport L., Tsarichenko D., Ganzha T., Krupinov G.
The role of kallikrein-kinin and renin-angiotensin system in the pathogenesis of prostate cancer
Kogan M., Chernogubova E., Chibichjan M., Macionis A., Povilajtite P., Matishov D.
EVALUATION OF DIAGNOSTIC SIGNIFICANCE OF PELVIC MRI IN PROSTATE CANCER PATIENTS
Rasner P., Kotenko D., Kolontarev K., Brodeckiy B., Pushkar D.
Anatomic-clinical criteria for prediction of continence after radical retropubic prostatectomy
Loran O., Lukyanov I., Al Khariri M., Sinitsyn V., Motalov V., Bakunovich A.
The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia
Alyaev Y., Vinarov A., Demidko Y., Spivak L.
DETECTION OF PROSTATE CANCER BASED ON MONITORING OF PROSTATE-SPECIFIC ANTIGEN IN OUTPATIENT CLINIC
Kamalov A., Maksimov V., Takhirzade T., Gevorgyan A., Okhobotov D., Avakyan A., Vasilyeva E.
PRIMENENIE PROSTAGUT FORTE U BOL'NYKh ADENOMOY PREDSTATEL'NOY ZhELEZY S SOPUTSTVUYuShchIM KhRONIChESKIM PROSTATITOM
Avdoshin V., Pulbere S.
Administration of vitaprost plus for prevention of infectious-inflammatory complications of transurethral prostatic resection in patients with prostatic adenoma
Nozdrachev N., Neymark A., Neymark B., Nozdrachev N., Neimark A., Neimark B.
Three-year results of a clinical study of prostamol Uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression
Vinarov A., Alyaev Y., Apolikhin O., Mazo E., Darenkov S., Demidko Y., Lokshin K., Medvedev A., Permyakova O., Spivak L., Shkol'nikov M., Vinarov A., Alyaev Y., Apolikhin O., Mazo E., Darenkov S., Demidko Y., Lokshin K., Medvedev A., Permyakova O., Spivak L., Shkolnikov M.
COMBINATION DRUG THERAPY IN PATIENTS WITH BPH
Kuz’menko A., Kuz’menko V., Gyaurgiev T.
TRANSABDOMINAL AND TRANSRECTAL ULTRASOUND ASSESSMENT OF INTRAVESICAL PROSTATIC PROTRUSION
Krivoborodov G., Efremov N., Bolotov A.
Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-naive prostate cancer
Matveev V., Kirichek A., Filippova M., Savinkova A., Khalmurzaev O., Lyubchenko L.
Super-selective prostatic artery embolization for bph treatment
Karpov V., Kapranov S., Shaparov B., Osmolovskiy B., Kamalov D., Kamalov A.
Factors predicting the development of urinary tract disorders in prostatic hyperplasia in elderly men
Dudarev V., Startsev V.
Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms
Amdii R., Al’-Shukri A.
COMPARISON OF FUNCTIONAL OUTCOMES AFTER RETROPUBIC AND ROBOT-ASSISTED RADICAL NERVE-SPARING PROSTATECTOMY CONDUCTED BY SURGEONS WITH TOTAL CASELOADS OF OVER 1000 PROSTATECTOMIES
Pushkar D., Dyakov V., Vasilyev A., Kotenko D.
The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination
Alyaev Y., Pshikhachev A., Perekalina A.
PROSTATE CANCER DETECTION BY ASSESSING STIFFNESS OF DIFFERENT TISSUES USING SHEAR WAVE ULTRASOUND ELASTOGRAPHY
Glybochko P., Alyaev Y., Amosov A., Krupinov G., Ganzha T., Vorob’ev A., Lumpov I., Semendyaev R.
Periprostatic inflammation as a risk factor for the development of vesico-urethral stenosis after radical prostatectomy
Chibichyan M., Kogan M., Lapteva T., Belousov I., Ivanov A., Chernogubova E.
Quality of life in patients undergoing prostate cryoablation
Govorov A., Vasil'ev A., Pushkar' D.
TREATMENT OF PROSTATE CANCER USING CRYOABLATION: A PROSPECTIVE STUDY
Govorov A., Vasiliev A., Ivanov V., Kovylina M., Prilepskaya E., Pushkar D.
FIRST EXPERIENCE OF HO:YAG LASER URETHROTOMY IN THE TREATMENT OF STRICTURES IN PATIENTS WITH PROSTATE CANCER
Lebedinets A., Shkolnik M., Timofeev D.
Obstructive complications of brachytherapy: endoscopic methods of treatment
Martov A., Abdullaev D., Dzhalilov D.
THE EVALUATION OF EFFICACY AND SAFETY OF TREATMENT WITH DALFAZ SR IN PATIENTS WITH PROSTATIC ADENOMA
Rasner P., Yu Pushkar D.
AFALA IN THE TREATMENT OF PATIENTS WITH BPH: EFFICACY AND SAFETY
Grigoriev M.
ESTIMATION OF THE RISK AND PREVENTION OF POSTOPERATIVE ESOPHAGOGASTRODUODENAL HEMORRHAGE IN ELDERLY UROLOGICAL PATIENTS
Leschenko I., Yakovlev O., Sidash B., Lazarev I., Shakhotina I.
Approaches to more effective radical prostatectomy
Apolikhin O., Katibov M., Apolikhin O., Katibov M.
Treatment of prostatic ADENOMA
Borisov V., Borisov V.
Efficacy of spinal-epidural anesthesia in elderly urologic patients
Nasirova R., Nasirova R.
Evaluation of long-term results of the use of entomological drug in the combination therapy of patients with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A., Kuzmenko V., Gyaurgiev T., Kuzmenko G.
RATIONALE OF PHARMACOTHERAPY DURATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (A CLINICAL-MORPHOLOGICAL STUDY)
Sitdykova M., Tsyplakov D., Sitdykov E., Nurtdinov A.
A case of successful plasma transurethral enucleationof benign prostatic hyperplasia the size of 530 cm3
Sevryukov F., Nakagawa K., Kochkin A., Volodin M., Semenychev D.
Prostate cysts
Martov A., Khistny D.
Morphological criteria for progression risk in patients with prostate cancer after radiation therapy
Shabanov M., Potapova A., Gladilina I., Rotobelskaya L.
1 - 100 的 203 信息 1 2 3 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##